Stifel Financial Corp Guardant Health, Inc. Transaction History

Stifel Financial Corp

$91.8 Billion
Q1 2025

A detailed history of Stifel Financial Corp transactions in Guardant Health, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 48,593 shares of GH stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,593

Previous 49,927 2.67%

Holding current value

$1.86 Million

Previous $1.53 Million 35.74%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$31.77 - $49.94 $42,381 - $66,619	-1,334 Reduced 2.67%	48,593 $2.07 Million
Q4 2024 Feb 13, 2025	BUY	$20.2 - $38.11 $202,121 - $381,328	10,006 Added 25.06%	49,927 $1.53 Million
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $5,218 - $8,491	-234 Reduced 0.58%	39,921 $915,000
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $229,029 - $453,783	14,252 Added 55.02%	40,155 $1.16 Million
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $786,044 - $1.23 Million	-45,887 Reduced 63.92%	25,903 $534,000
Q4 2023 Feb 12, 2024	SELL	$21.58 - $29.5 $118,021 - $161,335	-5,469 Reduced 7.08%	71,790 $1.94 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $163,262 - $252,930	-6,328 Reduced 7.57%	77,259 $2.29 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $163,562 - $296,896	7,811 Added 10.31%	83,587 $2.99 Million
Q1 2023 May 12, 2023	BUY	$22.92 - $33.76 $183,428 - $270,181	8,003 Added 11.81%	75,776 $1.78 Million
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $740,405 - $1.74 Million	-29,104 Reduced 30.04%	67,773 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $412,237 - $575,962	9,442 Added 10.8%	96,877 $5.22 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $165,080 - $443,060	5,728 Added 7.01%	87,435 $3.53 Million
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $284,144 - $591,785	5,889 Added 7.77%	81,707 $5.41 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.52 Million - $2.06 Million	17,146 Added 29.22%	75,818 $7.58 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $441,106 - $590,271	-4,466 Reduced 7.07%	58,672 $7.33 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $1.38 Million - $2.08 Million	12,538 Added 24.78%	63,138 $7.84 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $464,712 - $655,147	3,658 Added 7.79%	50,600 $7.73 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $85,565 - $116,356	856 Added 1.86%	46,942 $6.05 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $80,801 - $112,470	-1,006 Reduced 2.14%	46,086 $5.15 Million
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $88,859 - $143,227	-1,469 Reduced 3.03%	47,092 $3.82 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $2.68 Million - $4.03 Million	45,400 Added 1436.25%	48,561 $3.39 Million
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $28,971 - $40,313	-487 Reduced 13.35%	3,161 $251,000
Q3 2019 Nov 13, 2019	SELL	$62.59 - $110.3 $517,431 - $911,850	-8,267 Reduced 69.38%	3,648 $226,000
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $761,845 - $1.09 Million	11,915 New	11,915 $1.03 Million

Others Institutions Holding GH

# of Institutions

393

Shares Held

121M

Call Options Held

1.43M

Put Options Held

2.37M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.9B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Guardant Health, Inc. Transaction History